Literature DB >> 632363

Pharmacologic studies with cefaclor, a new oral cephalosporin.

B R Meyers, S Z Hirschman, G Wormser, G Gartenberg, E Srulevitch.   

Abstract

Cefaclor, a new oral cephalosporin, was administered to 18 normal human volunteers in either single or multiple doses of 250 and 500 mg. Mean serum concentrations of 6.09 and 12.8 microgram/ml were achieved 1 hour after single oral doses of 250 and 500 mg, respectively. The serum concentrations declined rapidly and no drug was detected at 4 hours. Very high concentrations of cefaclor were found in urine during the first 8 hours after ingestion of the drug. Forty-three per cent of the total dose was excreted in urine during the first 8 hours. There was no accumulation of drug in serum during the multiple-dose studies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632363     DOI: 10.1002/j.1552-4604.1978.tb01590.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  8 in total

1.  Phase I study of multiple-dose cefprozil and comparison with cefaclor.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; R R Martin; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Cefaclor: summary of clinical experience.

Authors:  R B Kammer; L J Short
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  Pharmacokinetics of cephradine given intravenously with and without probenecid.

Authors:  D H Roberts; M J Kendall; D B Jack; P G Welling
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

4.  Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage period.

Authors:  B Hampel; H Lode; J Wagner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

5.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

6.  Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.

Authors:  A Iravani; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

7.  [In vitro activity of cefaclor (author's transl)].

Authors:  H Knothe
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  [Investigations on the excretion of cefaclor in human bile (author's transl)].

Authors:  O Müller; U Rückert; K Fabricius
Journal:  Infection       Date:  1979       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.